Safe administration of sotrovimab to a COVID-19 patient with acute phase type 1 diabetes mellitus
Description
Type 1 diabetes mellitus (T1DM) and poor glycemic control are risk factors for severe coronavirus disease 2019 (COVID-19). Sotrovimab can treat mild-to-moderate COVID-19 in patients at a high risk of progression to severe COVID-19. However, its
